{
    "id": "dbpedia_1441_1",
    "rank": 50,
    "data": {
        "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC230463/",
        "read_more_link": "",
        "language": "en",
        "title": "Developmental abnormalities in mice transgenic for bovine oncostatin M.",
        "top_image": "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0",
        "meta_img": "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0",
        "images": [
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg",
            "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/logo-molcellb.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "N Malik",
            "H S Haugen",
            "B Modrell",
            "M Shoyab",
            "C H Clegg"
        ],
        "publish_date": "1995-05-31T00:00:00",
        "summary": "",
        "meta_description": "Oncostatin M belongs to the subfamily of hematopoietin cytokines that binds a receptor complex containing gp130. To date, only the human form of oncostatin M has been identified, and its evolutionary conservation is unresolved. We have isolated a bovine ...",
        "meta_lang": "en",
        "meta_favicon": "https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico",
        "meta_site_name": "PubMed Central (PMC)",
        "canonical_link": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC230463/",
        "text": "Mol Cell Biol. 1995 May; 15(5): 2349–2358.\n\nPMCID: PMC230463\n\nPMID: 7739518\n\nDevelopmental abnormalities in mice transgenic for bovine oncostatin M.\n\nAbstract\n\nOncostatin M belongs to the subfamily of hematopoietin cytokines that binds a receptor complex containing gp130. To date, only the human form of oncostatin M has been identified, and its evolutionary conservation is unresolved. We have isolated a bovine gene whose open reading frame encodes a precursor protein that is 58% identical to human oncostatin M. A comparison of the bovine and human amino acid sequences predicts significant similarity, including the four-alpha-helical-bundle structure and the placement of disulfide bridges. As with the human protein, bovine oncostatin M binds specific receptors on human H2981 cells and inhibits the proliferation of human A375 tumor cells and mouse M1 leukemia cells. To identify activities regulated in vivo, we injected bovine oncostatin M fusion genes containing various tissue-specific promoters into mouse embryos. The frequencies of transgenic mice were reduced significantly, suggesting that overexpression of the bovine cytokine is detrimental to normal mouse development. In addition to deaths associated with expression in neurons and keratinized epithelia, bovine oncostatin M caused abnormalities in bone growth and spermatogenesis, stimulated fibrosis surrounding islets in the pancreas, and disrupted normal lymphoid tissue development. This work establishes the existence of a nonprimate oncostatin M gene and provides the first demonstration that this cytokine can function in a pleiotropic manner in vivo. Information regarding bovine oncostatin M may help characterize the structure and function of this cytokine in other vertebrate species.\n\nFull Text\n\nThe Full Text of this article is available as a PDF (1.0M).\n\nSelected References\n\nThese references are in PubMed. This may not be the complete list of references from this article.\n\nAkira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. [PubMed] [Google Scholar]\n\nAruffo A, Seed B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8573–8577. [PMC free article] [PubMed] [Google Scholar]\n\nBamber BA, Masters BA, Hoyle GW, Brinster RL, Palmiter RD. Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7839–7843. [PMC free article] [PubMed] [Google Scholar]\n\nBazan JF. Neuropoietic cytokines in the hematopoietic fold. Neuron. 1991 Aug;7(2):197–208. [PubMed] [Google Scholar]\n\nBentz H, Thompson AY, Armstrong R, Chang RJ, Piez KA, Rosen DM. Transforming growth factor-beta 2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3. Matrix. 1991 Aug;11(4):269–275. [PubMed] [Google Scholar]\n\nBrinster RL, Chen HY, Warren R, Sarthy A, Palmiter RD. Regulation of metallothionein--thymidine kinase fusion plasmids injected into mouse eggs. Nature. 1982 Mar 4;296(5852):39–42. [PubMed] [Google Scholar]\n\nBrown TJ, Liu J, Brashem-Stein C, Shoyab M. Regulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor expression by oncostatin M. Blood. 1993 Jul 1;82(1):33–37. [PubMed] [Google Scholar]\n\nBrown TJ, Rowe JM, Liu JW, Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol. 1991 Oct 1;147(7):2175–2180. [PubMed] [Google Scholar]\n\nBruce AG, Hoggatt IH, Rose TM. Oncostatin M is a differentiation factor for myeloid leukemia cells. J Immunol. 1992 Aug 15;149(4):1271–1275. [PubMed] [Google Scholar]\n\nBruce AG, Linsley PS, Rose TM. Oncostatin M. Prog Growth Factor Res. 1992;4(2):157–170. [PubMed] [Google Scholar]\n\nCampbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10061–10065. [PMC free article] [PubMed] [Google Scholar]\n\nCampbell IL, Hobbs MV, Dockter J, Oldstone MB, Allison J. Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am J Pathol. 1994 Jul;145(1):157–166. [PMC free article] [PubMed] [Google Scholar]\n\nChaffin KE, Beals CR, Wilkie TM, Forbush KA, Simon MI, Perlmutter RM. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 1990 Dec;9(12):3821–3829. [PMC free article] [PubMed] [Google Scholar]\n\nDavis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 1993 Jun 18;260(5115):1805–1808. [PubMed] [Google Scholar]\n\nDavis S, Aldrich TH, Valenzuela DM, Wong VV, Furth ME, Squinto SP, Yancopoulos GD. The receptor for ciliary neurotrophic factor. Science. 1991 Jul 5;253(5015):59–63. [PubMed] [Google Scholar]\n\nEscary JL, Perreau J, Duménil D, Ezine S, Brûlet P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature. 1993 May 27;363(6427):361–364. [PubMed] [Google Scholar]\n\nFattori E, Della Rocca C, Costa P, Giorgio M, Dente B, Pozzi L, Ciliberto G. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood. 1994 May 1;83(9):2570–2579. [PubMed] [Google Scholar]\n\nGearing DP, Bruce AG. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. New Biol. 1992 Jan;4(1):61–65. [PubMed] [Google Scholar]\n\nGearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, et al. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. [PubMed] [Google Scholar]\n\nHilton DJ, Hilton AA, Raicevic A, Rakar S, Harrison-Smith M, Gough NM, Begley CG, Metcalf D, Nicola NA, Willson TA. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994 Oct 17;13(20):4765–4775. [PMC free article] [PubMed] [Google Scholar]\n\nHorn D, Fitzpatrick WC, Gompper PT, Ochs V, Bolton-Hansen M, Zarling J, Malik N, Todaro GJ, Linsley PS. Regulation of cell growth by recombinant oncostatin M. Growth Factors. 1990;2(2-3):157–165. [PubMed] [Google Scholar]\n\nJeffery E, Price V, Gearing DP. Close proximity of the genes for leukemia inhibitory factor and oncostatin M. Cytokine. 1993 Mar;5(2):107–111. [PubMed] [Google Scholar]\n\nLinsley PS, Kallestad J, Ochs V, Neubauer M. Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M. Mol Cell Biol. 1990 May;10(5):1882–1890. [PMC free article] [PubMed] [Google Scholar]\n\nLiu J, Modrell B, Aruffo A, Marken JS, Taga T, Yasukawa K, Murakami M, Kishimoto T, Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem. 1992 Aug 25;267(24):16763–16766. [PubMed] [Google Scholar]\n\nLo D, Burkly LC, Widera G, Cowing C, Flavell RA, Palmiter RD, Brinster RL. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell. 1988 Apr 8;53(1):159–168. [PubMed] [Google Scholar]\n\nLow MJ, Hammer RE, Goodman RH, Habener JF, Palmiter RD, Brinster RL. Tissue-specific posttranslational processing of pre-prosomatostatin encoded by a metallothionein-somatostatin fusion gene in transgenic mice. Cell. 1985 May;41(1):211–219. [PubMed] [Google Scholar]\n\nMalik N, Graves D, Shoyab M, Purchio AF. Amplification and expression of heterologous oncostatin M in Chinese hamster ovary cells. DNA Cell Biol. 1992 Jul-Aug;11(6):453–459. [PubMed] [Google Scholar]\n\nMalik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, Marquardt H, Zarling JM, Shoyab M, Wei CM, et al. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol. 1989 Jul;9(7):2847–2853. [PMC free article] [PubMed] [Google Scholar]\n\nMetcalf D, Gearing DP. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5948–5952. [PMC free article] [PubMed] [Google Scholar]\n\nMetcalf D, Waring P, Nicola NA. Actions of leukaemia inhibitory factor on megakaryocyte and platelet formation. Ciba Found Symp. 1992;167:174–187. [PubMed] [Google Scholar]\n\nMiles SA, Martínez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF, Linsley PS. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science. 1992 Mar 13;255(5050):1432–1434. [PubMed] [Google Scholar]\n\nPeschon JJ, Behringer RR, Brinster RL, Palmiter RD. Spermatid-specific expression of protamine 1 in transgenic mice. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5316–5319. [PMC free article] [PubMed] [Google Scholar]\n\nPlowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, Shoyab M. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol. 1990 May;10(5):1969–1981. [PMC free article] [PubMed] [Google Scholar]\n\nPlowman GD, Green JM, Neubauer MG, Buckley SD, McDonald VL, Todaro GJ, Shoyab M. The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. J Biol Chem. 1992 Jun 25;267(18):13073–13078. [PubMed] [Google Scholar]\n\nRao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH, Zigmond RE, Brulet P, Landis SC. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron. 1993 Dec;11(6):1175–1185. [PubMed] [Google Scholar]\n\nRao MS, Symes A, Malik N, Shoyab M, Fink JS, Landis SC. Oncostatin M regulates VIP expression in a human neuroblastoma cell line. Neuroreport. 1992 Oct;3(10):865–868. [PubMed] [Google Scholar]\n\nRogers KV, Boring LF, McKnight GS, Clegg CH. Promoter for the regulatory type I beta subunit of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase directs transgene expression in the central nervous system. Mol Endocrinol. 1992 Oct;6(10):1756–1765. [PubMed] [Google Scholar]\n\nRose TM, Bruce AG. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8641–8645. [PMC free article] [PubMed] [Google Scholar]\n\nRose TM, Lagrou MJ, Fransson I, Werelius B, Delattre O, Thomas G, de Jong PJ, Todaro GJ, Dumanski JP. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22. Genomics. 1993 Jul;17(1):136–140. [PubMed] [Google Scholar]\n\nShaw G, Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986 Aug 29;46(5):659–667. [PubMed] [Google Scholar]\n\nShen MM, Skoda RC, Cardiff RD, Campos-Torres J, Leder P, Ornitz DM. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J. 1994 Mar 15;13(6):1375–1385. [PMC free article] [PubMed] [Google Scholar]\n\nSkonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992 Sep;11(7):511–522. [PubMed] [Google Scholar]\n\nSporeno E, Paonessa G, Salvati AL, Graziani R, Delmastro P, Ciliberto G, Toniatti C. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. J Biol Chem. 1994 Apr 15;269(15):10991–10995. [PubMed] [Google Scholar]\n\nStewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992 Sep 3;359(6390):76–79. [PubMed] [Google Scholar]\n\nSymes AJ, Rao MS, Lewis SE, Landis SC, Hyman SE, Fink JS. Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):572–576. [PMC free article] [PubMed] [Google Scholar]\n\nThoma B, Bird TA, Friend DJ, Gearing DP, Dower SK. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem. 1994 Feb 25;269(8):6215–6222. [PubMed] [Google Scholar]\n\nVassar R, Fuchs E. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev. 1991 May;5(5):714–727. [PubMed] [Google Scholar]\n\nZarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9739–9743. [PMC free article] [PubMed] [Google Scholar]\n\nZhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, et al. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med. 1994 Apr 1;179(4):1337–1342. [PMC free article] [PubMed] [Google Scholar]\n\nArticles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis"
    }
}